Today's signals · No active technical signal.
Signal details →Enlivex Therapeutics last closed at $0.3620 (-6.53%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is 0.0×. Its overall grade ranks 402 of 741 stocks in Healthcare.
About this company
Enlivex Therapeutics last closed at $0.3620 (-6.53%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 402/741
Valuation grade B-
Related stocks
- Janssen PharmaceuticalsCustomer
Enlivex의 주력 후보물질 개발과 관련해 공동개발/임상 협력 가능성이 언급된 대형 제약사로 투자자 관점에서 중요
- RocheCompetitor
면역질환·염증질환 치료제 개발 경쟁에서 글로벌 대형 제약사로 직접 비교되는 경쟁사
- AbbVieCompetitor
면역·염증 분야 대형 파이프라인 보유사로 Enlivex가 노리는 치료영역의 핵심 경쟁사
About Enlivex Therapeutics
- What technical signals does Enlivex Therapeutics (ENLV) have?
- Enlivex Therapeutics current technical signals: no active technical signal.
- Is Enlivex Therapeutics a cup-and-handle pattern?
- No. Enlivex Therapeutics has no valid Cup signal right now.
- What published figures are available for Enlivex Therapeutics?
- Market cap: $5.73M. Trailing 12 months PER: 0.0×. Latest quarter PBR: 0.00×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Enlivex Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.